Essex Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $12.1K | Hold |
|
|||||
|
2023
Q2 | $14.9K | Sell |
|
|||||
|
2023
Q1 | $21.8K | Hold |
|
|||||
|
2022
Q4 | $20K | Sell |
|
|||||
|
2022
Q3 | $1.19M | Buy |
|
|||||
|
2022
Q2 | $760K | Sell |
|
|||||
|
2022
Q1 | $1.93M | Sell |
|
|||||
|
2021
Q4 | $2.49M | Sell |
|
|||||
|
2021
Q3 | $3.8M | Buy |
|
|||||
|
2021
Q2 | $5.48M | Sell |
|
|||||
|
2021
Q1 | $4.33M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3.51M | Sell |
|
|||||
|
2020
Q2 | $3.09M | Sell |
|
|||||
|
2020
Q1 | $2.18M | Sell |
|
|||||
|
2019
Q4 | $5.08M | Buy |
|
|||||
|
2019
Q3 | $3.23M | Sell |
|
|||||
|
2019
Q2 | $4.03M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.41M | Buy |
|
|||||
|
2018
Q1 | $996K | Sell |
|
|||||
|
2017
Q4 | $1.2M | Buy |
|